Infantile hemangioma presented in a neonatal patient at the Dr. Roberto Gilbert E Hospital. Report of a case
Article Sidebar
Main Article Content
Abstract
Introduction: Infantile hemangioma is considered the most common benign endothelial tumor in childhood with an incidence of 4-10% in children under 1 year of age. Clinical case: This is a 20-day-old newborn who presents an erythematous lesion with well-defined borders that gradually increases in size and intensity, involving the right auricular region, neck and left auricular region, classified as a deep hemangioma that presented as a complication airway obstruction, managed clinically with propranolol. Discussion: It seems in the first weeks of life, the predominant location is the head and neck, as in the case of our patient. Its approach and treatment are multidisciplinary given its size, location site and high risk of sequelae.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Baselga Torres E, Bernabéu Wittel J, van Esso Arbolave DL, Febrer Bosch MI, Carrasco Sanz Á, de Lucas Laguna R, Del Pozo Losada J, Hernández Martín Á, Jiménez Montañés L, López Gutiérrez JC, Martín-Santiago A, Redondo Bellón P, Ruíz-Canela Cáceres J, Torrelo Fernández A, Vera Casaño Á, Vicente Villa MA. Consenso español sobre el hemangioma infantil [Spanish consensus on infantile haemangioma]. An Pediatr (Barc). 2016 Nov;85(5):256-265. Spanish. doi: 10.1016/j.anpedi.2015.10.004. Epub 2015 Nov 19. PMID: 26776166.
Rodríguez Bandera AI, Sebaratnam DF, Wargon O, Wong LF. Infantile hemangioma. Part 1: Epidemiology, pathogenesis, clinical presentation and assessment. J Am Acad Dermatol. 2021 Dec;85(6):1379-1392. doi: 10.1016/j.jaad.2021.08.019. Epub 2021 Aug 19. PMID: 34419524.
Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet. 2017 Jul 1;390(10089):85-94. doi: 10.1016/S0140-6736(16)00645-0. Epub 2017 Jan 13. PMID: 28089471.
Krowchuk DP, Frieden IJ, Mancini AJ, Darrow DH, Blei F, Greene AK, Annam A, Baker CN, Frommelt PC, Hodak A, Pate BM, Pelletier JL, Sandrock D, Weinberg ST, Whelan MA; SUBCOMMITTEE ON THE MANAGEMENT OF INFANTILE HEMANGIOMAS. Clinical Practice Guideline for the Management of Infantile Hemangiomas. Pediatrics. 2019 Jan;143(1):e20183475. doi: 10.1542/peds.2018-3475. PMID: 30584062.
Wendling-Keim DS, Wanie L, von Schweinitz D, Grantzow R, Kappler R. Transcriptional activation of Hedgehog pathway components in aggressive haemangioma. Exp Dermatol. 2017 Oct;26(10):934-939. doi: 10.1111/exd.13346. Epub 2017 Aug 15. PMID: 28370639.
Lockman J, Schwartz Alan. Infantile hemangioma in the Airway. Anesthesiology. 2015;123(6):1449.
Cheirif-Wolosky O, Novelo-Soto AD, Orozco-Covarrubias L, Sáez-de-Ocariz M. Infantile hemangioma: an update in the topical and systemic treatments. Bol Med Hosp Infant Mex. 2019;76(4):167-175. English. doi: 10.24875/BMHIM.19000002. PMID: 31303649.
Jung HL. Update on infantile hemangioma. Clin Exp Pediatr. 2021 Nov;64(11):559-572. doi: 10.3345/cep.2020.02061. Epub 2021 May 26. PMID: 34044479; PMCID: PMC8566803.
Cheng JWCH, Lam YY, Fung GPG, Sin C, Luk DCK, Chan BHB, Chiu WK. Randomised controlled trial: Can topical timolol maleate prevent complications for small superficial infantile haemangiomata in high-risk areas? Pediatr Res. 2020 Nov;88(5):756-760. doi: 10.1038/s41390-020-0917-3. Epub 2020 May 1. PMID: 32357362.
Pope E, Lara-Corrales I, Sibbald C, Liy-Wong C, Kanigsberg N, Drolet B, Ma J. Noninferiority and Safety of Nadolol vs Propranolol in Infants With Infantile Hemangioma: A Randomized Clinical Trial. JAMA Pediatr. 2022 Jan 1;176(1):34-41. doi: 10.1001/jamapediatrics.2021.4565. PMID: 34747977; PMCID: PMC8576629